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Abstract
Background: Although the efficacy of computerized clinical decision support (CCDS) for acute kidney injury (AKI) remains
unclear, thewider literature includes examples of limited acceptability and equivocal benefit. Our single-centre study aimed to
identify factors promoting or inhibiting use of in-patient AKI CCDS.
Methods: Targeting medical users, CCDS triggered with a serum creatinine rise of ≥25 μmol/L/day and linked to guidance
and test ordering. User experience was evaluated through retrospective interviews, conducted and analysed according to
Normalization Process Theory. Initial pilot ward experience allowed tool refinement. Assessments continued following CCDS
activation across all adult, non-critical care wards.
Results: Thematic saturation was achieved with 24 interviews. The alert was accepted as a potentially useful prompt to early
clinical re-assessment by many trainees. Senior staff were more sceptical, tending to view it as a hindrance. ‘Pop-ups’ and
mandated engagement before alert dismissal were universally unpopular due to workflow disruption. Users were driven to
close out of the alert as soon as possible to review historical creatinines and to continue with the intended workflow.
Conclusions: Our study revealed themes similar to those previously described in non-AKI settings. Systems intruding on
workflow, particularly involving complex interactions, may be unsustainable even if there has been a positive impact on care.
The optimal balance between intrusion and clinical benefit of AKI CCDS requires further evaluation.
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Introduction
Acute kidney injury (AKI) is common [1], dangerous [2–5] and cost-
ly [1]. Unfortunately, AKI care is also often poor [6, 7]. Education
must play a role in addressing this, but our previous work has
shown that knowledge gaps are still evident evenwhenAKI teach-
ing is established [8]. The heterogeneity and complexity of AKI
may compound difficulties in establishing good practice [9, 10].
Computerized clinical decision support (CCDS) has been pro-
moted as a solution to these problems [11]. Unfortunately, there is
apaucityofevidenceofefficacy,andthewider literaturehasdemon-
strated problems with implementation and integration of other
CCDS systems [12–14], with previous initiatives failing due to lack
of user engagement in development and implementation [13].
There is a pressing need to evaluate not just quantitative out-
comes but also user acceptability and its place within clinical
workflows. Our study sought to identify those factors promoting
or inhibiting use of an in-patient AKI CCDS system through end-
user interviews and quantitative evaluation of their interaction
with it. This study was part of a broader, mixed-methods evalu-
ation that also included assessments of impact on practice and
outcomes.
Materials and methods
AKI CCDS context and functionality
The studywas conductedwithin our 1800-bed,multiple-site hos-
pital. The renal unit, based at one of two acute sites, provides
consultative input for AKI patients across the region.
In-patient records comprised written bedside documentation
and an electronic patient record (EPR) for medicines manage-
ment and test ordering and resulting (Cerner Millennium, Cerner
Corporation, USA). The EPR already generated alerts interruptive
of workflow (e.g. drug review prompts) and non-intrusive, back-
ground flags (e.g. noting previous Clostridium difficile infection).
AnAKI CCDSwas developedwithin the EPR by two co-authors
(A.H., N.S.K.) to highlight in-patient AKI and link to guidance. An
intrusive alert triggered when the individual patient’s EPR was
first accessed by medical staff after a serum creatinine (Cr) rise
of ≥25 μmol/L/day. Correction to a daily rate of rise allowed for in-
stances when Cr testing was less frequent. Setting of the trigger
above diagnostic thresholds [9] was intended to minimize alert
fatigue and pre-dated a nationalmandate [11]. In this exploratory
study, only one AKI episode was triggered/admission, although
the alert, itself, might present multiple times depending on
user interaction with it.
The initial alert box highlighted possible AKI, noted the avail-
ability of clinical decision support (CDS) and hyperlinked to the
local AKI protocol. A mandatory interaction then opened a
menu window that required users to choose:
(i) To bypass the alert (if EPR accessed in error or by non-home
team clinician),
(ii) An exclusion: if receiving dialysis/end-of-life care, or
(iii) ‘None of the above’.
The alert could then be signed off, although optional links to local
protocol and easy reference lists for essential assessments and
investigations were available. The latter allowed quick ordering
of test panels (e.g. essential bloods, urgent renal ultrasound).
From initial alert to close out required at least four clicks. Option
(i) made the alert dormant until the EPR was next accessed; the
others de-activated it for the duration of the admission. All
choices left a visible log on the biochemistry flowchart.
The following were excluded:
• The renal unit (due to erroneous alerts with dialysis),
• Critical and coronary care, transplantation areas (due to dialy-
sis and the local spectrum of AKI),
• Patients <18 years old.
Triggers were prevented on patients who had deceased or dis-
charged between the trigger Cr and first EPR access.
Implementation
Our study comprised three phases:
• Phase 1 (16 weeks): rolling implementation of the CCDS sys-
tem across three pilot wards (Elderly Medicine, General Sur-
gery, Internal Medicine) with usual practice continuing
across the rest of the organization,
• A planned 8-week hiatus to allow CCDS refinement,
• Phase 2 (16weeks): activation of the revised CCDS across all 64
target wards,
• Further CCDS refinement, if required,
• Phase 3 (4 weeks): to assess the impact of the revised tool
across all 64 target wards.
Publicity was undertaken through:
• On-site distribution of help sheets to Phase 1 wards,
• E-mail cascades, including the revised help sheet, 6 weeks
prior to Phase 2,
• Incorporation within the standard training delivered to newly
qualified doctors startingwithin the organization, 4 days prior
to Phase 3.
Study timelines were as follows:
• Phase 1: 12 August–2 December 2013,
• Phase 2: 8 April–29 July 2014,
• Phase 3: 8 August–5 September 2014.
The longer than anticipated hiatus before Phase 2 was required
for reconfiguration of the tool following feedback and for refine-
ment of diagnostic algorithms.
Qualitative evaluation
Procedures followed were in accordance with the ethical stan-
dards of the Local Research Ethics Committee (Ref. 12/NE/0278)
and with the Helsinki Declaration of 1975, as revised in 2000.
Recruits were purposively sampled from those who had had
experience of the alert. After informed consent, face-to-face
interviews of ∼60 min duration were conducted by one of the
co-authors, M.T.B. (an experienced qualitative researcher), on
hospital premises, adopting an open-ended approach (i.e. with-
out using leading questions, allowing the informant to take the
lead and probing revealed themes in depth). Interviews were
audio-recorded and transcribed using QSR Nvivo computer data
analysis software (QSR International, Victoria, Australia) and
analysed for identifiable themes according to the standard proce-
dures of rigorous qualitative analysis (inductive coding, constant
comparison, deviant case analysis) [15]. Recruitment continued
in each phase until thematic saturation had occurred (i.e. when
no new themes were emerging at successive interviews). The in-
terviews were conducted and findings categorized within the
framework of Normalization Process Theory (NPT) [16, 17]. NPT
proposes that complex interventions only become integrated
into existing practice through individual and collective imple-
mentation. This requires ongoing investment by individuals
2 | N.S. Kanagasundaram et al.
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and groups in order to ensure continued use and occurs via four
mechanisms:
Coherence: how people make sense of what needs to be done.
Cognitive participation: how relationships with others influ-
ence outcomes.
Collective action: how people work together to make practices
work.
Reflexive monitoring: how people assess the impact of the new
intervention.
Each interview themewas therefore assigned to one of these four
NPT mechanisms with participant statements extracted to high-
light issues of significance for both end users and developers.
Phase 3 interviewees were limited to AKI CCDS naïve doctors.
Inconvenience payments were offered based on hourly locum
rates.
Quantitative evaluation of end-user interactions
Three patient cohorts (n = 280, each) were identified for a separate
evaluation of outcomes and practice. These comprised consecu-
tively triggering patients from: (i) immediate go-live, Phase 2; (ii)
12 weeks post-go-live, Phase 2; and (iii) immediate go-live, Phase
3. Alert bypass rates were compared across patient cohorts using
‘R’ with a two-sample test for equality of proportions and a sig-
nificance level of 5%. The use of exclusions and test panel order-
ing were recorded.
Results
Pre-Phase 2 CCDS changes
The alert text was re-configured to include the trigger Cr and up
to two preceding results depending on which was recognized as
the reference value. The need to exercise clinical judgement
about minor rises in very frequent Crs was emphasized. Greater
prominence was given to guidance links within the menu win-
dow, which also now included a free text option for exclusions
and a link to the drug chart, interaction with which was made
mandatory.
Pre-Phase 3 CCDS changes
Following Phase 2 feedback, alert interaction was made non-
mandatory. Alert appearance was limited to five/admission
with no repeat alert for any individual user for 4 h. The alert
text was further simplified (figure 1a; figure 1b shows the subse-
quent menu window).
Qualitative interview findings
Thematic saturation was achieved with 24 interviews (Table 1).
Trainees, in particular, found a coherent link between the
alert and patient care, investing it with greater importance than
other alerts due to its perceived relevance. Because of this, they
were more likely to undertake earlier patient reassessment.
A typical response is shown in Table 2 (Quote 3.1.1—Phase 3, Re-
spondent 1, Quote 1).
Actions prompted by the alert did not always get explicitly
documented as such because they were perceived as normal
medical activities.
Mandated interaction clearly irritated users, with the highest
emotional response coming from senior staff. Unlike trainees
whoworked together to navigate the CCDS, senior staff struggled
to use it. Apart from having ‘too many clicks’, it was cited as an
insult to their knowledge; suspicion was expressed of a clandes-
tine audit process (Table 2, Quote 2.3.1).
This response illustrated the impact onworkflowof alerts that
could not be immediately dismissed or minimized to enable the
primary activity to continue. Because of more frequent use, trai-
nees often found ways to bypass it. However, rather than pre-
venting the alert from appearing again, bypassing it simply hid
it until the next time the patient’s chart was accessed. Workflow
Fig. 1. (a) Final, Phase 3 alert text. (b) Subsequent menu window.
Table 1. Numbers interviewed broken down by study phase,
specialism and gradea
Phase 1 Phase 2 Phase 3 Total
Medicine
Foundation traineeb 2 1 3 6
Speciality traineec 0 1 0 1
Consultantd 0 4 0 4
Surgery
Foundation trainee 4 1 0 5
Speciality trainee 0 1 1 2
Consultant 0 0 0 0
Care of the elderly
Foundation trainee 4 2 0 6
Speciality trainee 0 0 0 0
Consultant 0 0 0 0
Total 10 10 4 24
aNo participant was interviewedmore than once. Forty-six staff were approached
about participation. The most common reason for refusal was lack of time.
bTrainees within 2 years of post-graduation.
cSenior trainees.
dSenior clinicians ≡ attending/staff clinicians.
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interruption was the dominant reason for dislike of the alert but
reflected interviewees’ antipathy to all EPR pop-ups.
Amajor driver for alert dismissal was users’ need to view his-
torical biochemistry to allow clinical decision-making and priori-
tization. This came at the expense of lack of engagement with
guidance and test ordering. Even when Cr data were introduced
into the Phase 2 alert, users still referred back to more compre-
hensive data to assess alert credibility. Technical limitations pre-
vented presentation of detailed Cr data within the alert box
(Table 2, Quote 2.6.1).
In themain, the alert was seen as credible and enhanced cog-
nitive participation (Table 2, Quote 2.6.2). Alert credibility was
sometimes strained, though, when it was felt to be too sensitive.
Lack of awareness of even lower diagnostic thresholds for AKI
was evident, but interviewees also identified instances when
an alert appeared not to be associated with an elevation in
serum Cr (Table 2, Quote 1.7.1). This may have been explained
by unaccounted anomalies in the alert (e.g. patient transfer
from a non-alerting venue to a study ward) or by a recurring
alert that had just been bypassed and ignored by others.
Participants openly expressed concern about alert fatigue
(Table 2, Quote 3.2.1). The only new interview finding in Phase 3
was that the revised alert proved to be more acceptable because
of increased ease of dismissal (Table 2, Quote 3.2.2).
Finally, it was evident that at least some users were unaware
of CDS functionality downstream of the initial alert (e.g. test or-
dering, best practice checklists); when its availability was pointed
out to them they did feel that this was of potential use.
Quantitative evaluation of end-user interactions
High rates of bypassing were found and increased as Phase 2 pro-
gressed (Table 3). Free text exclusion comments often queried the
trigger threshold (e.g. ‘no rise’), suggested prior knowledge of AKI
(e.g. ‘known acute renal failure post CABG’) or offered an alterna-
tive explanation (e.g. ‘previous renal transplant’, ‘pregnancy/
postnatal’). Minimal use of test panel ordering was evident in
the three patient cohorts from (i) immediate go-live, Phase 2
cohort (5.4%), (ii) 12 weeks post-go-live, Phase 2 (7.5%), and (iii)
immediate go-live, Phase 3 (1.1%).
Discussion
CCDS for AKI has been widely promoted [11, 18]. Although a uni-
form detection algorithm is now mandated across England and
Wales [11], the end-user interface may still vary, for instance, in
terms of alert intrusion, its mode of delivery and mandation of
interaction. Even a single, uniform interface may not suit all cir-
cumstances. There is, therefore, a pressing and well-recognized
[1, 18] need for evaluation of implementation, function and im-
pact on practice. The evidence, however, remains limited and
conflicting.
One prospective, single-centre, intensive care study found
that interruptive text alerts led to more timely intervention and
more rapid resolution of AKI [19]. However, over 90% of alerts
were generated for changes in urine output, alone, suggesting
that the intervention was addressing an early, pre-renal re-
sponse. Moreover, mortality and the need for renal support
were unaffected. Another single-centre, parallel group study
[20] randomized patients with serum Cr-based AKI to usual
care or an interruptive text alert to their clinician and found no
difference in outcome, but with some evidence of increased re-
source utilization. Neither study explored end-user acceptability
or the social context of their alerts.
Table 2. Interviewee quotes
Quote
3.1.1 “It is quick and it is simple, it highlights something you
should be looking at anyway but it is, you know, always
nice to safety net yourself and make sure you definitely
review even if it is something you are aware of at the time.”
2.3.1 “I couldn’t bypass it and I haven’t had any training or been
told about this form. There was no way I could bypass the
form. I couldn’t. I was so irritated by it I tried to bypass it
and proceed and don’t have the answers to subsequent
questions . . . I closed the whole system and went on to
another system and then I asked the juniors what they had
been doing.”
2.6.1 “I think it’s not that you don’t trust it, it’s just it’s difficult to
see the severity of it without seeing the blood results. The
creatinine may have gone up by thirty or by one hundred
and you still get the same warning. Obviously one needs a
lot faster action than the other one really . . . so I think that
is why I want to see the blood results.”
2.6.2 “So it pops up I look down the patient list see kind of how long
ago their operation was and what they’ve come in with,
and then I go through and write down a list of the bloods
that we haven’t just done on the patient, then I click
through the blood results and I like to look through their
notes to see if they have changed anything, any
medications and then I go and see them and look at the
urine output. That is how it usually goes, then I send off the
bloods or order the ultrasound.”
1.7.1 “I didn’t really go [to see the patient]. I just looked back to the
last week and her U&Es were normal so I just ignored it
[laughs]. I don’t know if it was an earlier warning that
hadn’t been properly dealt with but it kept flagging up, but,
yeah and in that instance there wasn’t an AKI.”
3.2.1 “To be completely honest it looks just like all the pop-ups we
get. A lot of them are aboutmedications we prescribed and
they have been one off doses and they have stayed on the
system and you deleted them. So . . . and I have to admit
some of them I have gotten used to just clicking dismiss
and carrying on . . . but I have noticed when I’ve had this
one and I have gone and actually looked at their bloods.”
3.2.2 “I thought it was great . . . it justmeans you definitely look at
it twice and make sure it wasn’t something you needed to
do intervention wise.”
Table 3. End-user use of bypass function across study phases
Immediate
go-live,
Phase 2
12 weeks
post-go-live,
Phase 2
Total number of alert forms completed 998 1101
Total number of bypasses 788 918
Alert form bypass rate (%) 79* 83*
Median number of bypasses per patient 3 3
Median number of bypasses per doctor 2 (1–22) 2 (1–20)
*P = 0.01.
Each alert form could be completed (i.e. closed out) by bypassing, recording an
exclusion or recording an acknowledgment of the form (by clicking option (iii):
‘None of the above’—see the text for details).
In Phase 3, immediate alert dismissal avoided theneed for subsequent interaction
with the CCDS (the AKI form was completed in only 3/280 alerting patients).
4 | N.S. Kanagasundaram et al.
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Even when beneficial [21–23], other CCDS systems may have
negative impacts including delayed treatment [14]. The limited evi-
dence of patient benefitwas illustrated in one review [24] that found
only 57% of studies affected user behaviour with only 30% able to
demonstrate an effect on patient outcomes. The negative impact
of top-down solutions, without ‘end-user pull’ in tailoring CCDS,
has beenemphasized [13, 25], but specific pointsof end-user dissat-
isfaction include alert fatigue [12, 26–29], mandated responses (that
are frequently bypassed if workflows are disrupted [30]) and the
complexity of clinical decision-making—far from facilitating pa-
tient management, CCDS may complicate it by forcing the user to
interpret the solution they have been presented with [13]. Without
understanding how technologies, people and organizations dy-
namically interact [31, 32] and the importance of pre-existing atti-
tudes [33], it will remain unclear how to tailor and integrate more
complex CCDS (such as for AKI) within existing practice.
We believe our study is the first to undertake qualitative
evaluation of an AKI CCDS system and has revealed precisely
those themes warned of in the generic literature—alert fatigue,
user dissatisfaction and antipathy to mandatory interactions
and intrusion.
Development of our system included extensive pilot work, but
the broader picture of discontentwas only revealed later. Addition-
ally, ourpreconceivedbelief in theadvantagesofavisibleaudit trail
within the biochemistry flowsheet and of exclusion recording to
block further alerts was negated by antipathy to mandated inter-
action which these apparent benefits required. Although mindful
of the risks of top-down solutions, our study has revealed the
need for an end-user responsive process that, we feel, must extend
well beyond initial scoping and implementation.
We found limited engagement with CDS functionality, down-
stream of the original alert (e.g. test ordering). Lack of awareness
was evident, but we speculate that the drive for rapid alert dis-
missal was an important explanatory factor—when this was fa-
cilitated in Phase 3, test panel ordering and the rate of form
completion fell off sharply.
An impression of over-sensitive alerting affected the tool’s
credibility for some. Although this may have reflected poor
awareness of current diagnostic thresholds, many patients may
never achieve a Cr higher than the one initially triggering even
a Stage 1 AKI alert [20]. If alerts are only being generated when
AKI is already resolving, one can speculate upon the negative im-
pact on even initially positive end users.
Our study has a number of caveats.
Firstly, our tool was developed in-house and required experien-
tial learning tomeet some user demands. Although not an explicit
interview finding, delays may have affected the tool’s credibility.
Secondly, the pre-Phase 2 educational roll-out proved to have had
limited reach, requiring a supplementary cascade after 10 weeks;
this, we feel, probably reflected the shortfall in educational re-
source needed to inform a large, multiple-site organization. Third-
ly, our CCDS was not intended as an exhaustive surveillance tool.
Missed episodes of AKI (due to the higher-than-diagnostic trigger
threshold or because this was a repeat AKI episode) might have
affected credibility, although this was not apparent in interviews.
Fourthly, users were only interviewed once, so temporal changes
in experience may have been missed. Finally, we acknowledge
that user culture in Phase 2might have been affected by discussion
with pilot ward participants, although we feel it would have been
difficult to avoid this in a single-centre study.
We believe that our study offers important lessons about the
implementation, integration and acceptability of AKI CCDS. Its
significancewas its congruencywithmedical practice, appearing
to prompt earlier patient reassessment at least amongst some
trainees. Our study has, however, also revealed those themes
that have affected other CCDS implementations. Systems intrud-
ing onworkflow, particularly involving complex ormandatory in-
teractions, may not be sustainable even if there has been a
positive impact on care. Although conducted in a single institu-
tion within the National Health Service of England and Wales,
we believe that our study has relevance to other healthcare com-
munities, all of whom will face common challenges of clinical
prioritization, efficiency ofworkflowand effective team-working,
even if the solutions to these may differ. Further evaluation is
needed of the optimal balance between intrusion and clinical
benefit as well as of the applicability of our findings across differ-
ent information technology capabilities and clinical settings.
Acknowledgements
We are extremely grateful to study participants for the generous
use of their time and to the Northern Counties Kidney Research
Fund, NHS Kidney Care, the Newcastle Health Care Charity and
the Newcastle upon Tyne Hospitals NHS Charity for funding of
our work. We acknowledge the support of the National Institute
for Health Research, through the Local Clinical Research Network.
Conflict of interest statement
None declared. This work was presented in abstract form at
the joint meeting of the EDTA-ERA and UK Renal Association,
London, May 2015.
References
1. NICE. Acute kidney injury: prevention, detection and man-
agement of acute kidney injury up to the point of renal re-
placement therapy. NICE clinical guideline 169: National
Institute for Health and Care Excellence, 2013
2. Lassnigg A, Schmidlin D, Mouhieddine M et al. Minimal
changes of serum creatinine predict prognosis in patients
after cardiothoracic surgery: a prospective cohort study. J
Am Soc Nephrol 2004; 15: 1597–1605
3. Uchino S, Bellomo R, Goldsmith D et al. An assessment of the
RIFLE criteria for acute renal failure in hospitalized patients.
Crit Care Med 2006; 34: 1913–1917
4. Kuitunen A, Vento A, Suojaranta-Ylinen R et al. Acute renal
failure after cardiac surgery: evaluation of the RIFLE classifi-
cation. Ann Thorac Surg 2006; 81: 542–546
5. Ahlstrom A, Kuitunen A, Peltonen S et al. Comparison of 2
acute renal failure severity scores to general scoring systems
in the critically ill. Am J Kidney Dis 2006; 48: 262–268
6. Stewart J, Findlay G, Smith N et al. Adding Insult to Injury: A
Review of the Care of Patients Who Died in Hospital with a
Primary Diagnosis of Acute Kidney Injury (Acute Renal
Failure). London: National Confidential Enquiry into Patient
Outcome and Death, 2009
7. Stevens PE, Tamimi NA, Al-Hasani MK et al. Non-specialist
management of acute renal failure. QJM 2001; 94: 533–540
8. Muniraju TM, Lillicrap MH, Horrocks JL et al. Diagnosis and
management of acute kidney injury: deficiencies in the
knowledge base of non-specialist, trainee medical staff. Clin
Med 2012; 12: 216–221
9. Lewington A, Kanagasundaram S. Renal Association Clinical
Practice Guidelines on acute kidney injury. Nephron Clin Pract
2011; 118 (Suppl. 1): c349–c390
10. KDIGO. KDIGO Clinical Practice Guideline for Acute Kidney
Injury. Kidney Int Suppl 2012; 2: 1–138
Qualitative evaluation of CCDS for AKI | 5
C
L
IN
IC
A
L
K
ID
N
E
Y
JO
U
R
N
A
L
 at U
niversity of N
ew
castle on D
ecem
ber 18, 2015
http://ckj.oxfordjournals.org/
D
ow
nloaded from
 
11. Patient safety alert on standardising the early identification of Acute
Kidney Injury. https://www.england.nhs.uk/2014/06/09/psa-
aki/ (24 April 2015, date last accessed)
12. Gurwitz JH, Field TS, Rochon P et al. Effect of computerized
provider order entry with clinical decision support on ad-
verse drug events in the long-term care setting. J Am Geriatr
Soc 2008; 56: 2225–2233
13. Rousseau N, McColl E, Newton J et al. Practice based, longitu-
dinal, qualitative interview study of computerised evidence
based guidelines in primary care. BMJ 2003; 326: 314–318
14. Strom BL, Schinnar R, Aberra F et al. Unintended effects of a
computerized physician order entry nearly hard-stop alert
to prevent a drug interaction: a randomized controlled trial.
Arch Intern Med 2010; 170: 1578–1583
15. Strauss AL. Qualitative Analysis for Social Scientists. Cambridge:
Cambridge University Press, 1987
16. May C, Finch T. Implementation, embedding, and integra-
tion: an outline of Normalization Process Theory. Sociology
2009; 43: 535–554
17. May CR, Mair F, Finch T et al. Development of a theory of im-
plementation and integration: Normalization Process The-
ory. Implementation Sci 2009; 4: 29
18. Feehally J, Gilmore I, Barasi S et al. RCPEUK consensus confer-
ence statement:management of acute kidney injury: the role
of fluids, e-alerts and biomarkers. J R Coll Physicians Edinb
2013; 43: 37–38
19. Colpaert K, Hoste EA, Steurbaut K et al. Impact of real-time
electronic alerting of acute kidney injury on therapeutic
intervention and progression of RIFLE class. Crit Care Med
2012; 40: 1164–1170
20. Wilson FP, Shashaty M, Testani J et al. Automated, electronic
alerts for acute kidney injury: a single-blind, parallel-group,
randomised controlled trial. Lancet 2015; 385: 1966–1974
21. Kucher N, Koo S, Quiroz R et al. Electronic alerts to prevent
venous thromboembolism among hospitalized patients. N
Engl J Med 2005; 352: 969–977
22. Finlay-Morreale HE, Louie C, Toy P. Computer-generated
automatic alerts of respiratory distress after blood transfu-
sion. J Am Med Inform Assoc 2008; 15: 383–385
23. Dexter PR, Perkins S, Overhage JM et al. A computerized re-
minder system to increase the use of preventive care for hos-
pitalized patients. N Engl J Med 2001; 345: 965–970
24. Jaspers MW, Smeulers M, Vermeulen H et al. Effects of clin-
ical decision-support systems on practitioner perfor-
mance and patient outcomes: a synthesis of high-quality
systematic review findings. J Am Med Inform Assoc 2011;
18: 327–334
25. Cresswell K, Majeed A, Bates DW et al. Computerised decision
support systems for healthcare professionals: an interpret-
ative review. Inform Prim Care 2012; 20: 115–128
26. Kesselheim AS, Cresswell K, Phansalkar S et al. Clinical deci-
sion support systems could be modified to reduce ‘alert fa-
tigue’ while still minimizing the risk of litigation. Health Aff
(Millwood) 2011; 30: 2310–2317
27. Embi PJ, Leonard AC. Evaluating alert fatigue over time to
EHR-based clinical trial alerts: findings from a randomized
controlled study. J Am Med Inform Assoc 2012; 19 (e1):
e145–e148
28. Lee EK, Mejia AF, Senior T et al. Improving patient safety
through medical alert management: an automated decision
tool to reduce alert fatigue. AMIA Annu Symp Proc 2010; 2010:
417–421
29. Bates DW, Kuperman GJ, Wang S et al. Ten commandments
for effective clinical decision support: making the practice
of evidence-based medicine a reality. J Am Med Inform Assoc
2003; 10: 523–530
30. Litzelman DK, TierneyWM. Physicians’ reasons for failing to
comply with computerized preventive care guidelines. J Gen
Intern Med 1996; 11: 497–499
31. Kaplan B. Evaluating informatics applications—some
alternative approaches: theory, social interactionism, and
call for methodological pluralism. Int J Med Inform 2001; 64:
39–56
32. Wears RL, Berg M. Computer technology and clinical work:
still waiting for Godot. JAMA 2005; 293: 1261–1263
33. Kitson A, Harvey G, McCormack B. Enabling the implementa-
tion of evidence based practice: a conceptual framework.
Qual Health Care 1998; 7: 149–158
6 | N.S. Kanagasundaram et al.
C
L
IN
IC
A
L
K
ID
N
E
Y
JO
U
R
N
A
L
 at U
niversity of N
ew
castle on D
ecem
ber 18, 2015
http://ckj.oxfordjournals.org/
D
ow
nloaded from
 
